Saharan, Sahdev

Saharan, Sahdev was paid $674K by Medicaid between Jan 2018 and Dec 2021, across 9 billing codes. Its largest line is J0717, Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) — 71% of everything it billed.

33Billing provider infoSAHARAN, SAHDEV
TRACY, CA 95376

33aNPI1588875512assigned 05/24/2007

33bProvider typeRheumatology Physician

28Total paid$674K

24GClaims2,251

24DCodes billed9

24AFirst – last monthJan 2018 – Dec 2021

Compared with peers

Next to other Rheumatology Physician providers in California

Rank by total paid#26 of 147

Median peer was paid$43K

This provider vs. median16×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	2,194	$662K
2019	12	$900.85
2021	45	$11K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	71%	191	181	$480K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	14%	937	928	$97K
99244	Office or other outpatient consultation, moderate to high complexity	6.6%	234	234	$44K
96401		3.3%	137	128	$22K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	2.6%	246	240	$17K
20610		1.1%	134	128	$8K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	166	165	$3K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	192	188	$2K
J1020	Injection, methylprednisolone acetate, 20 mg	<1%	14	14	$261.51

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.